ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 6.05% of NRXP shares are held by financial institutions. MORGAN STANLEY is the top corporate investor, holding 670 shares valued at $24.00K. A 0% stake in NRx Pharmaceuticals, Inc. is owned by the company. WEALTHCARE ADVISORY PARTNERS LLC owns 375 shares valued at $13.00K, which translates its holding of 0% of the stake in the company.
Among the NRXP insiders holding of 23.56% of the stake in company, JAVITT DANIEL C., director, holds the largest shares of 9.63M. HURVITZ CHAIM, director, is the second largest NRXP insider with ownership of 570K shares. POLAR ASSET MANAGEMENT PARTNERS INC., 10 percent owner, stands third with possession of 488.04K shares of that stake.